CD79b-directed Antibody–Drug Conjugates

Name
CD79b-directed Antibody–Drug Conjugates
Accession Number
DBCAT005702
Description

Antibody-drug conjugates in which the antibody portion is directed towards CD79b.

Drugs
DrugDrug Description
Polatuzumab vedotinA CD79b antibody conjugate indicated to treat different types of large B-cell lymphoma.
Drugs & Drug Targets
DrugTargetType
Polatuzumab vedotinCytochrome P450 3A4enzyme
Polatuzumab vedotinB-cell antigen receptor complex-associated protein beta chaintarget
Polatuzumab vedotinP-glycoprotein 1transporter
Polatuzumab vedotinCytochrome P450 3A5enzyme